SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Salary: USD 232,000 - 245,000 / annual
Celea Therapeutics is a clinical-stage biotech company dedicated to advancing transformative treatments for serious respiratory diseases. The company's lead program, deupirfenidone (LYT-100), is in Phase 3 clinical development for idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases.
Reporting to the Chief Operating Officer, you will serve as the company's day-to-day owner for corporate communications and will build and execute an integrated external communications program. This is a Director-level individual contributor role designed for someone who can think strategically while personally writing, coordinating, organizing, and executing communications work.
Key responsibilities include:
• Own Celea's integrated communications workplan, ensuring external messaging is clear, consistent, scientifically credible, regulatorily appropriate, and aligned with company strategy.
• Develop, write, and maintain core corporate external-facing materials, including corporate decks, external presentations, conference materials, press releases, executive talking points, Q&A documents, website updates, and social media content.
• Partner with executive leadership, Finance, Legal, Clinical, Medical Affairs, and external advisors to support corporate objectives, including conference planning with medical affairs, Q&A preparation, and company communications processes.
• Partner with Leadership and HR on internal communications, providing strategic messaging and communications support for employee announcements, program rollouts, company news, and organizational updates.
• Translate complex clinical, scientific, regulatory, and commercial information into balanced, accurate, audience-appropriate messaging for healthcare stakeholders, media, prospective employees, patients, and caregivers.
• Lead proactive and reactive communications around corporate, clinical, financing, conference, and business milestones, balancing planned news flow with opportunistic visibility opportunities.
• Build a communications function with public-company discipline while staying close to the science, strategy, and people behind the mission.
The ideal candidate combines biotechnology communications judgment, excellent writing skills, disciplined project management, and comfort working in a lean environment where external agency partners, legal counsel, finance, clinical, medical affairs, and executive leaders must stay tightly aligned.
Celea is preparing for its next stage of clinical, corporate, and capital markets growth, making this a pivotal role in shaping the company's external narrative during a critical period.
Qualifications (inferred from role description):
• Demonstrated experience in biotechnology or life sciences communications
• Strong writing and editing capabilities
• Project management discipline and ability to coordinate across multiple stakeholders
• Understanding of clinical development, regulatory processes, and healthcare communications
• Ability to translate complex scientific and clinical information for diverse audiences
• Experience managing external agency partners and cross-functional teams
• Comfort in lean, fast-moving environments
